Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
4(33%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
4
33%
Ph phase_3
2
17%
Ph phase_4
5
42%
Ph phase_1
1
8%

Phase Distribution

1

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
5(41.7%)
N/ANon-phased studies
4(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

12

all time

Status Distribution
Active(5)
Completed(5)
Other(2)

Detailed Status

Completed5
Recruiting4
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 32 (16.7%)
Phase 45 (41.7%)
N/A4 (33.3%)

Trials by Status

not_yet_recruiting18%
completed542%
recruiting433%
unknown217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12